Deal Corners

HTML PDF


Deal Corner January 20, 2017

MSD divests 6 brands to Zydus Healthcare Limited

DEAL BRIEF

United States pharmaceutical giant Merck & Co., Inc. (known as Merck Sharp & Dohme (MSD) outside the United States and Canada), through its subsidiaries, divested its 6 brands to Zydus Cadila’s wholly owned subsidiary Zydus Healthcare Limited. Pharmaceutical products in the segment of men’s and women’s health, wound management and cardiovascular therapy were sold under these brands.

In addition to the sale of brand names, Organon India Private Limited, an Indian subsidiary company of Merck & Co., Inc. /MSD, assigned manufacturing know-how, distribution and commercialization rights for 3 of the brands sold as part of the deal.

Press coverage relating to this transaction available at Business Standard, Economic Times, Live Mint and Pharma Biz.

OUR ROLE

We, at Nishith Desai Associates, acted as the Indian legal and regulatory counsel to MSD.

Mission and Vision


Distinctly Different


Webinars

Will Drones ever fly in India?
December 05, 2017

This event is over. For event material please click here


Seminar

Innovation in Digital Economy - Transforming a Trillion Dollar Potential to Reality
December 07, 2017

This event is over. For event material please click here


Round Table

Evolving Structures and Trends for Distressed M&A/PE in India post the New Bankruptcy Code
November 23, 2017

This event is over. For event material please click here

Want to work with us?


HIRING Now!!

Inviting Top Talent for our Corporate, Funds and International Tax Practices

Strong credentials in Corporate Law (in particular M&A or Fund Investment), Fund Formation or International Tax? Now’s the time to apply. We’re looking for the industry's best talent with scope to do extraordinary work for the world’s best, marquee clients. Reach out for a great career in a great place!

Write to happiness(at)nishithdesai.com


TO LEARN MORE ABOUT US

CLICK HERE.


Nishith Desai Associates 2013. All rights reserved.